Literature DB >> 15294075

In vitro selection of RNA aptamers against the HCV NS3 helicase domain.

Fumiko Nishikawa1, Kohei Funaji, Kotaro Fukuda, Satoshi Nishikawa.   

Abstract

Nonstructural protein 3 (NS3) of hepatitis C virus (HCV) has two distinct domains, protease and helicase, that are essential for HCV proliferation. Therefore, NS3 is considered a target for anti-HCV treatment. To study RNA aptamers of the NS3 helicase domain, we carried out in vitro selection against the HCV NS3 helicase domain. RNA aptamers obtained after eight generations possessed 5' extended single-stranded regions and the conserved sequence (5'-GGA(U/C)GGAGCC-3') at stem-loop regions. Aptamer 5 showed strong inhibition of helicase activity in vitro. Deletion and mutagenesis analysis clarified that the conserved stem-loop is important and that the whole structure is needed for helicase inhibition. We compared the inhibition of helicase activity between aptamer 5 and 3'+-UTR of HCV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15294075     DOI: 10.1089/1545457041526335

Source DB:  PubMed          Journal:  Oligonucleotides        ISSN: 1545-4576


  17 in total

Review 1.  Aptamers as a novel tool for diagnostics and therapy.

Authors:  Onat Kadioglu; Anna Helena Malczyk; Henry Johannes Greten; Thomas Efferth
Journal:  Invest New Drugs       Date:  2015-02-01       Impact factor: 3.850

2.  Selection and characterization of RNA aptamers to the RNA-dependent RNA polymerase from foot-and-mouth disease virus.

Authors:  Mark Ellingham; David H J Bunka; David J Rowlands; Nicola J Stonehouse
Journal:  RNA       Date:  2006-10-03       Impact factor: 4.942

Review 3.  Prospects for nucleic acid-based therapeutics against hepatitis C virus.

Authors:  Chang Ho Lee; Ji Hyun Kim; Seong-Wook Lee
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

Review 4.  The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target.

Authors:  David N Frick
Journal:  Curr Issues Mol Biol       Date:  2007-01       Impact factor: 2.081

5.  Inhibition of both protease and helicase activities of hepatitis C virus NS3 by an ethyl acetate extract of marine sponge Amphimedon sp.

Authors:  Yuusuke Fujimoto; Kazi Abdus Salam; Atsushi Furuta; Yasuyoshi Matsuda; Osamu Fujita; Hidenori Tani; Masanori Ikeda; Nobuyuki Kato; Naoya Sakamoto; Shinya Maekawa; Nobuyuki Enomoto; Nicole J de Voogd; Masamichi Nakakoshi; Masayoshi Tsubuki; Yuji Sekiguchi; Satoshi Tsuneda; Nobuyoshi Akimitsu; Naohiro Noda; Atsuya Yamashita; Junichi Tanaka; Kohji Moriishi
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

Review 6.  Unzippers, resolvers and sensors: a structural and functional biochemistry tale of RNA helicases.

Authors:  Ana Lúcia Leitão; Marina C Costa; Francisco J Enguita
Journal:  Int J Mol Sci       Date:  2015-01-22       Impact factor: 5.923

Review 7.  Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses.

Authors:  Víctor M González; M Elena Martín; Gerónimo Fernández; Ana García-Sacristán
Journal:  Pharmaceuticals (Basel)       Date:  2016-12-16

8.  Aptamer-based therapeutics: new approaches to combat human viral diseases.

Authors:  Ka-To Shum; Jiehua Zhou; John J Rossi
Journal:  Pharmaceuticals (Basel)       Date:  2013-11-25

Review 9.  Aptamers against pathogenic microorganisms.

Authors:  Anna Davydova; Maria Vorobjeva; Dmitrii Pyshnyi; Sidney Altman; Valentin Vlassov; Alya Venyaminova
Journal:  Crit Rev Microbiol       Date:  2015-08-10       Impact factor: 7.624

10.  Pharmacokinetics of a Cholesterol-conjugated Aptamer Against the Hepatitis C Virus (HCV) NS5B Protein.

Authors:  Chang Ho Lee; Soo-Han Lee; Ji Hyun Kim; Yook-Hwan Noh; Gyu-Jeong Noh; Seong-Wook Lee
Journal:  Mol Ther Nucleic Acids       Date:  2015-10-06       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.